Evaluation of the 101 most cited immunology articles: A bibliometric analysis.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
21 Jul 2023
Historique:
medline: 24 7 2023
pubmed: 21 7 2023
entrez: 21 7 2023
Statut: ppublish

Résumé

In our study, the 101 most cited publications in the field of "Immunology" in the Web of Science (WoS) database were evaluated bibliometrically. The "WoS" database "advanced mode" was used in this study. A search was conducted in the field of "Immunology." The top 101 most-cited publications were then identified. The total number of citations of the publications, annual number of citations, authors, information of the study, and journal were analyzed. There were 1,191,384 publications in the field of "Immunology" in the WoS between 1975 and 2023. The total citation average of the 101 most cited publications was 3765.69 ± 4142.7 and the annual citation average was 180.91 ± 133.1. The first 3 subjects in the first 101 articles were listed as "apoptosis-cancer immunology" (14.85%), "monocyte-macrophage"(14.58%), and "T-cell"(13.86%), respectively. The 3 journals in which the studies were published the most were determined as "Annual Review of Immunology" (18.81%), "Nature Reviews Immunology" (17.82%) and "Nature Immunology" (10.89%). Only 1.98% of publications were published after 2014. A significant relationship was found between the study type, impact factor of the journal, continent of journal and publisher, funding status, year of publication, and number of citations per year (P < .05). Our study is the first to analyze the top 101 most-cited studies in the field of "immunology" and their citation characteristics. The study's journals, publishers, publication features, funding status, and publication year affect the number of citations per year.

Identifiants

pubmed: 37478253
doi: 10.1097/MD.0000000000034375
pii: 00005792-202307210-00048
pmc: PMC10662843
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e34375

Informations de copyright

Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc.

Déclaration de conflit d'intérêts

The authors have no funding and conflicts of interest to disclose.

Références

Front Immunol. 2020 Mar 12;11:259
pubmed: 32226424
Chin Med J (Engl). 2018 Dec 20;131(24):2968-2975
pubmed: 30539910
Biomark Med. 2022 Sep;16(13):1005-1017
pubmed: 36052709
Medicine (Baltimore). 2019 Feb;98(8):e14523
pubmed: 30813156
Iran J Allergy Asthma Immunol. 2019 Nov 05;18(6):688-700
pubmed: 32245313
Am J Public Health. 2000 Sep;90(9):1463-6
pubmed: 10983209
Biomed Pharmacother. 2021 Nov;143:112238
pubmed: 34649362
JAMA. 1987 Jan 2;257(1):52-9
pubmed: 3537352
Transplant Proc. 2017 Apr;49(3):551-561
pubmed: 28340832
Am J Emerg Med. 2016 Jul;34(7):1210-6
pubmed: 27066933
Int Immunopharmacol. 2019 Jul;72:374-384
pubmed: 31030093
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2204074119
pubmed: 35867747
Agri. 2021 Apr;33(2):53-63
pubmed: 33913129
J Cell Physiol. 2021 Jun;236(6):4121-4137
pubmed: 33230811
Rev Lat Am Enfermagem. 2018 Sep 03;26:e3051
pubmed: 30183876
Front Public Health. 2022 Aug 08;10:939053
pubmed: 36003630
Front Immunol. 2022 Mar 18;13:840956
pubmed: 35371087
Int J Dermatol. 2019 Sep;58(9):1023-1034
pubmed: 30315571
Mediators Inflamm. 2021 Jan 14;2021:8874339
pubmed: 33505220
PLoS One. 2017 Sep 19;12(9):e0184869
pubmed: 28926600
Geriatr Gerontol Int. 2017 Feb;17(2):357-360
pubmed: 28240456
PLoS One. 2016 Sep 09;11(9):e0162099
pubmed: 27611317
Medicine (Baltimore). 2023 Apr 25;102(17):e33607
pubmed: 37115058
Arch Ophthalmol. 2010 Dec;128(12):1610-7
pubmed: 21149789
Allergy Asthma Clin Immunol. 2018 Sep 12;14(Suppl 2):49
pubmed: 30263032
Medicine (Baltimore). 2018 Apr;97(15):e0276
pubmed: 29642147
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2282-2292
pubmed: 31169039
Acta Anaesthesiol Scand. 2003 Jul;47(6):655-63
pubmed: 12803581
Medicine (Baltimore). 2022 Jan 7;101(1):e28520
pubmed: 35029915
Front Immunol. 2022 Aug 12;13:969196
pubmed: 36032149
Minerva Med. 2021 Oct;112(5):631-640
pubmed: 34814634

Auteurs

Sevgi Yilmaz Hanci (S)

Microbiology and Clinical Microbiology Laboratory, Health Sciences University, İzmir Tepecik Training and Research Hospital, Izmir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH